Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Seratrodast | 112665-43-7 | 99.59% | 100 MG
SDP

Catalog No. 5000408254
Encompass_Preferred

Seratrodast (AA 2414) is an orally active antiasthmatic agent that functions as a thromboxane A2 receptor (TP) antagonist and a ferroptosis inhibitor. It reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits both anti-asthmatic and anti-epileptic activities.

  • Acts as a thromboxane A2 receptor (TP) antagonist
  • Functions as a ferroptosis inhibitor
  • Reduces lipid ROS production
  • Modulates the systemic xc-/GSH/GPX4 axis
  • Inhibits JNK phosphorylation and p53 expression
  • Exhibits anti-asthmatic activity
  • Exhibits anti-epileptic activity

Catalog No. 50-004-08254 Supplier Medchemexpress LLC Supplier No. HYB0774100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Seratrodast (AA 2414) is an orally active antiasthmatic agent that functions as a thromboxane A2 receptor (TP) antagonist and a ferroptosis inhibitor. It reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits both anti-asthmatic and anti-epileptic activities.

  • Acts as a thromboxane A2 receptor (TP) antagonist
  • Functions as a ferroptosis inhibitor
  • Reduces lipid ROS production
  • Modulates the systemic xc-/GSH/GPX4 axis
  • Inhibits JNK phosphorylation and p53 expression
  • Exhibits anti-asthmatic activity
  • Exhibits anti-epileptic activity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.